Conversion Disorder
Conversion disorder is a mental condition in which a person has blindness, paralysis, or other nervous system (neurologic) symptoms that cannot be explained by medical evaluation.
Cluster Number:
Wiki Number: W049
Diagnosis: Conversion Disorder
US Patients: 0.11-0.5%
World Patients:
Sex Ratio: 1M;4W
Age Onset: Ages-10-35
Brain Area: large epinephrine release
Symptoms: psychologically triggered neurological symptoms, numbness, blindness, paralysis or fits,etc.
Progression: Trauma suddenly converted by the brain into physical limitations.
Causes: serious difficulties when no physical basis can be found; usually in motor or sensory systems
Medications:
Therapies: hypnosis, psychotherapy, physical therapy, stress management, transcranial magnetic stimulation; depression may occur.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- To B- or not to B-: A review of lineage switched acute leukemiaby Jason H Kurzer on June 30, 2022
Acute leukemia is a heterogeneous disorder of hematologic malignancies composed primarily of hematopoietic precursors that have acquired unregulated self-renewal and proliferation. Hematology classification systems typically divide these neoplasms into lymphoid (B- or T-) and myeloid-lineage subtypes, with therapy dependent upon this distinction. Infrequently, certain acute leukemias may undergo a complete lineage switch at relapse, subsequently complicating the diagnosis and treatment of these...
- Chiari Malformation Type 1 in an Adolescent with Conversion Disorderby Seda Aybuke Sari on June 30, 2022
No abstract
- Odor identification predicts the transition of patients with isolated RBD: A retrospective studyby Tomoyuki Miyamoto on June 29, 2022
CONCLUSIONS: In IRBD patients, anosmia predicts a higher short-term risk of transition to LBD but cannot distinguish between PD and DLB. At baseline, preserved odor identification may occur in latent MSA. Future IRBD neuroprotective trials should evaluate anosmia as a marker of prodromal LBD.
- Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Diseaseby Ruihua Cao on June 27, 2022
REM sleep behavior disorder (RBD) is closely associated with Parkinson's disease (PD), however, the influence of dopaminergic replacement therapy (DRT) on the clinical course of RBD in PD remains less understood. The objective of our study is to investigate how DRTs modify the evolution of RBD in a longitudinal cohort study of initially de novo PD patients. Four hundred and five drug-naive patients with early-stage PD were included. RBD symptoms were assessed using the 10-item RBD Screening...